J9285 Olaratumab - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Olaratumab

Brand Name:

Lartruvo

Strength:

10 mg

HCPCS:

J9285

SEER*Rx Category:

Immunotherapy

Major Drug Class:

Monoclonal Antibody

Minor Drug Class:

PDGFR

Oral (Y/N):

No

FDA Approval Year:

2016

FDA Discontinuation Year:

CMS Effective Date:

April 1, 2017

CMS Discontinuation Date:

Status:

In Use